Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sameer Jauhar

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
BMC Psychiatry|April 3, 2012
Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?Sameer Jauhar, Sinan Guloksuz, Olivier Andlauer, et al.
Schizophrenia Bulletin|May 11, 2026
Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysisJack B Fanshawe, Cameron J Watson, Valentina Mancini, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 30, 2026
The proportion of people with primary affective disorders presenting to early intervention services: systematic review and meta-analysisAna Catalán, Samuel Swidzinski, Robert A McCutcheon, et al.
Molecular Psychiatry|June 23, 2021
Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET studyMaria Rogdaki, Céline Devroye, Mariasole Ciampoli, et al.
Molecular Psychiatry|May 13, 2021
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET studyMaria Rogdaki, Céline Devroye, Mariasole Ciampoli, et al.
Journal of Affective Disorders|May 29, 2025
The semi-structured interview for bipolar at-risk states (SIBARS): psychometric properties and validationRiccardo Stefanelli, Andrés Estradé, Matilda Azis, et al.
Biological Psychiatry Global Open Science|May 25, 2026
Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and PsychosisIsabelle Austin-Zimmerman, Qiang Li, Emma C Johnson, et al.
Translational Psychiatry|March 2, 2025
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging studyEllis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Frontiers in Psychiatry|March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling studyDominic Oliver, Cathy Davies, Fernando Zelaya, et al.
BMC Psychiatry|April 3, 2012
Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?Sameer Jauhar, Sinan Guloksuz, Olivier Andlauer, et al.
Schizophrenia Bulletin|May 11, 2026
Variability and Magnitude of Choline Levels Across the Psychosis Spectrum: A Meta-analysisJack B Fanshawe, Cameron J Watson, Valentina Mancini, et al.
Translational Psychiatry|August 13, 2021
N-methyl-D-aspartate receptor availability in first-episode psychosis: a PET-MR brain imaging studyKatherine Beck, Atheeshaan Arumuham, Mattia Veronese, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 30, 2026
The proportion of people with primary affective disorders presenting to early intervention services: systematic review and meta-analysisAna Catalán, Samuel Swidzinski, Robert A McCutcheon, et al.
Molecular Psychiatry|June 23, 2021
Correction: Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET studyMaria Rogdaki, Céline Devroye, Mariasole Ciampoli, et al.
Molecular Psychiatry|May 13, 2021
Striatal dopaminergic alterations in individuals with copy number variants at the 22q11.2 genetic locus and their implications for psychosis risk: a [18F]-DOPA PET studyMaria Rogdaki, Céline Devroye, Mariasole Ciampoli, et al.
Journal of Affective Disorders|May 29, 2025
The semi-structured interview for bipolar at-risk states (SIBARS): psychometric properties and validationRiccardo Stefanelli, Andrés Estradé, Matilda Azis, et al.
Biological Psychiatry Global Open Science|May 25, 2026
Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and PsychosisIsabelle Austin-Zimmerman, Qiang Li, Emma C Johnson, et al.
Translational Psychiatry|March 2, 2025
The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging studyEllis Chika Onwordi, Thomas Whitehurst, Ekaterina Shatalina, et al.
Pageof 14